Skip to main content
BTSG logo

BrightSpring Health Services, Inc. (BTSG) Stock: Price, Forecast & Analyst Target

BrightSpring Health Services, Inc. (BTSG) — MoonshotScore 87/100 (Exceptional band), calculated Nov 18, 2026. Price $64.02 (-6.32%), as of the Nov 19, 2026 trading session; market cap $12.7B.

Educational signal · not a buy or sell recommendation · How to read this

$64.02 −$4.32 (-6.32%) Market Cap $12.7B

BrightSpring Health Services, Inc. · BTSG · NASDAQ · Healthcare · Medical Healthcare Information Services

Research dated 2026-09-13 (results through Q2 FY2026; the quarter ended Sep 2026 not covered): BrightSpring delivers pharmacy and clinical services in patients’ homes and local communities, largely for people covered by government programs or commercial insurance. The case rests on whether rising care volume can keep lifting profit and cash generation while the company carries substantially more debt than cash.

Price as of Nov 19, 2026

Key Statistics

87 of 100

MoonshotScore v2 · BrightSpring Health Services (BTSG)

Exceptional
Business Quality Solid (75)
Financial Safety Strained (34)
Valuation Fair (70)
Growth Durability Compounding (99)
Momentum Surging (96)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and elite growth, but a strained balance sheet; the market is already moving on it. Business Quality: Solid; Financial Safety: Strained; Valuation: Fair; Growth Durability: Compounding; Momentum: Surging.

  • EPS beat 7 of the last 8 reports
  • Altman Z 4.99 · Piotroski F 7
  • ROE 15.5% · ROA 5.4% · current ratio 1.62

Holding back: balance-sheet strain

Helping: business quality, an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for BTSG (57 recorded, newest six shown)
RecordedScoreBand
86Exceptional
87Exceptional
86Exceptional
86Exceptional
87Exceptional
87Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$64.02
Change on the day-6.32%
52-week range$30.64–$73.75
Market capitalisation$12.7B—
Price / earnings (trailing)42.58
Shares traded on the day3.11M
Beta (volatility vs the S&P 500)1.78

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $30, high $73, latest $64. $73 $30 high $73 Oct 17, 2025 Nov 19, 2026 · $64 $30Oct 17, 2025$33Oct 31, 2025$32Nov 14, 2025$36Nov 28, 2025$37Dec 12, 2025$38Dec 26, 2025$38Jan 9, 2026$40Jan 23, 2026$40Feb 6, 2026$41Feb 20, 2026$41Mar 6, 2026$41Mar 20, 2026$43Apr 2, 2026$47Apr 17, 2026$53May 1, 2026$58May 15, 2026$62May 29, 2026$63Jun 12, 2026$69Jun 26, 2026$71Jul 10, 2026$73Jul 24, 2026$62Aug 7, 2026$59Aug 21, 2026$61Sep 4, 2026$57Sep 18, 2026$60Oct 2, 2026$61Oct 16, 2026$67Oct 30, 2026$71Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for BrightSpring Health Services (BTSG): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Weak
Valuation Moderate
Growth Durability Strong
Momentum Strong

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Moderate
Debt/Equity Negative
ROE Moderate
Gross Margin Weak

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 16, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is BrightSpring Health Services (BTSG), and what does it report?

Short answer · as of

BrightSpring is not primarily a healthcare information vendor.

Its revenue comes from pharmacy services, medical care and supportive assistance delivered through clinicians and licensed pharmacists near where patients live, with reimbursement tied to Medicare, Medicaid and private insurance.

Reported revenue therefore reflects a broad mix of medication fulfillment and patient care rather than software subscriptions. The company reports a large revenue base with comparatively narrow gross, operating and net margins, making service mix, reimbursement and operating discipline important to earnings.

2 · Latest results

What do the latest results show for BrightSpring Health Services (BTSG)?

The latest results extended a sustained rise in revenue, gross profit, operating profit and net income. Profit advanced faster than revenue across the recent sequence, while reported revenue and earnings also exceeded market estimates in the latest release.

Cash performance was less linear. Operating cash flow remained positive but fell sharply from the preceding period even as accounting profit increased, so the improvement in earnings has not yet translated into equally steady cash generation. Management expects stronger full-period cash conversion and lower leverage, but that remains an outlook to be tested against reported cash flow.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2026$4.21B$100M$0.45 (diluted)
Q2 FY2026$3.87B$87M$0.39 (diluted)
Q1 FY2026$3.61B$74M$0.34 (diluted)
Q4 FY2025$3.55B$77M$0.35 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for BrightSpring Health Services (BTSG)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

BrightSpring has produced positive operating cash flow throughout the reported sequence, and capital spending has remained modest relative to that inflow. The liquidity ratios and quality screens also indicate adequate near-term financial capacity.

Debt is the sharper constraint. Cash and investments cover only a minority of total borrowings, leaving the company in a substantial net-debt position while margins remain thin. A setback in reimbursement, pharmacy economics or care delivery costs could therefore compress earnings quickly and reduce room for acquisitions or balance-sheet flexibility.

4 · What to check next?

What should you watch next at BrightSpring Health Services (BTSG)?

Short answer · as of

Current published price targets run low $70.00 · high $92.00 · consensus $81.36 · median $80.00 against a quoted price of $64.02 (as of Nov 19, 2026).

Watch whether revenue, gross profit and operating profit continue rising together. Revenue growth without further operating leverage would suggest that added care and pharmacy volume is carrying too much incremental cost.

Cash conversion deserves equal weight: operating cash flow weakened in the latest period, while management has set a materially stronger full-period expectation and is evaluating the capital structure needed to support future growth. The scheduled earnings release should clarify whether cash generation is catching up with profit and whether debt is moving toward management’s stated leverage objective.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does BrightSpring Health Services compare with its peers?

Short answer

BrightSpring Health Services's score ranks 3rd of 6 in the bounded comparison shown, against 5 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

BrightSpring combines pharmacy operations with hands-on clinical and supportive care delivered in homes and communities. That makes it different from a pharmacy distributor, a clinic operator or a healthcare software company viewed in isolation: medication services and patient care sit on the same broad platform.

Its payer exposure also spans government programs and commercial insurance. Compared with businesses concentrated in a single care setting or payer channel, BrightSpring’s breadth can diversify demand, but it also exposes profitability to several reimbursement systems while the consolidated margin remains narrow.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Krystal Biotech, Inc. (KRYS) Named competitor$315.82 Nov 19, 2026$9.36B96 5-pillar Nov 18, 2026
HealthEquity, Inc. (HQY) Named competitor$97.31 Nov 18, 2026$8.05B90 5-pillar Nov 18, 2026
BrightSpring Health Services (BTSG) — this page$64.02$12.7B87
Chemed Corporation (CHE) Named competitor$551.33 Nov 19, 2026$7.15B85 5-pillar Nov 18, 2026
Bruker Corporation (BRKR) Named competitor$62.10 Nov 19, 2026$9.48B59 5-pillar Nov 18, 2026
CRISPR Therapeutics AG (CRSP) Named competitor$40.19 Nov 18, 2026$3.90B22 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$70.00 – $92.00
Consensus target
$81.36
Median target
$80.00

Consensus record · Captured .

Measured against a quoted price of $64.02 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 25, 2026

Transactions
25
Identified insiders
7
Purchases
0
Sales
7
Other transactions
18

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held BTSG in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Viking GlobalAndreas HalvorsenQ3 20260.21%$69.55MTrimmed −24.3% shares
Bridgewater AssociatesFounded by Ray DalioQ3 20260.07%$16.42MNew position

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about BrightSpring Health Services (BTSG)?

Read these with our analysis →

Common Questions About BTSG (Healthcare)

The last 2 questions are answered from this page's own dated data, not from the research.

What does BrightSpring provide in patients’ homes and communities?

BrightSpring provides pharmacy services, clinical care and supportive assistance through licensed pharmacists and clinical professionals. Demand is tied to the medication and care needs of insured patients outside traditional hospital settings.

Why does PharMerica matter to BrightSpring?

PharMerica represents BrightSpring’s pharmacy capability, with dedicated sales, account management and operating leadership. It helps distinguish the company from home-care providers that do not combine patient services with pharmacy operations.

Is BrightSpring’s recent profit improvement producing stronger cash flow?

Accounting profit has risen across the recent reporting sequence, but operating cash flow dropped in the latest period. Management’s cash-conversion outlook makes the gap between earnings and cash a key follow-through test.

How exposed is BrightSpring to Medicare, Medicaid and commercial insurance?

Those payer channels fund the pharmacy and provider services delivered to BrightSpring’s patients. Reported segment figures confirm meaningful Medicaid and commercial-insurance revenue, while the broader business description also identifies Medicare coverage.

What is the BTSG stock price today?

The last price recorded for BrightSpring Health Services, Inc. (BTSG), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the BTSG price target?

The analyst consensus price target for BrightSpring Health Services, Inc. (BTSG), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 25 figures on this page — 1 from SEC filings and earnings calls, 19 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Quarterly income statement (USD thousands); Cash, investments and debt; Operating cash flow by quarter (USD millions)
  • 1. What is BrightSpring Health Services (BTSG), and what does it report?: Sector / industry (provider taxonomy); Business description; Revenue by segment; Quarterly income statement (USD thousands); Trailing twelve-month ratio set
  • 2. What do the latest results show for BrightSpring Health Services (BTSG)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Operating cash flow by quarter (USD millions); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts; Most recent periodic reports
  • 3. What are the financial strengths and risks for BrightSpring Health Services (BTSG)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash against market value; Trailing twelve-month ratio set; Distress and quality screens; Business description
  • 4. What should you watch next at BrightSpring Health Services (BTSG)?: Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Management outlook — dated call excerpts; Next earnings report; Recent SEC filings
  • 5. How does BrightSpring Health Services compare with its peers?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Trailing twelve-month ratio set
  • FAQ: What does BrightSpring provide in patients’ homes and communities?: Business description
  • FAQ: Why does PharMerica matter to BrightSpring?: Named officers; Business description
  • FAQ: Is BrightSpring’s recent profit improvement producing stronger cash flow?: Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Management outlook — dated call excerpts
  • FAQ: How exposed is BrightSpring to Medicare, Medicaid and commercial insurance?: Business description; Revenue by segment
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold BTSG

Funds in our ETF coverage that list BTSG among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
XHS ETF2.33%
iShares Russell 2000 ETF (IWM)0.30%